Function of circulating TNF in rheumatoid arthritis patients with infliximab: Link to clinical response.

被引：0
作者：
Marotte, H
Miossec, P
机构：
[1] Hop Edouard Herriot, INSERM, U 403, Lyon, France
[2] Hop Edouard Herriot, Dept Immunol, Lyon, France
[3] Hop Edouard Herriot, Dept Rheumatol, Lyon, France
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
[21]   The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients [J].
Cheng, Peng ;
Wang, Jun .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (08)
[22]   Switching to etanercept in patients with rheumatoid arthritis with no response to infliximab. [J].
Di Poi, Emma ;
Perin, Antonella ;
Morassi, Maria Pia ;
Del Frate, Marino ;
Ferraccioli, Gianfranco ;
De Vita, Salvatore .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) :85-87
[23]   Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy [J].
Gómez-Puerta, JA ;
Sanmartí, R ;
Rodríguez-Cros, JR ;
Cañete, JD .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) :896-896
[24]   Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab [J].
Sanmartí, R ;
Gómez-Puerta, JA ;
Rodríguez-Cros, JR ;
Albaladejo, C ;
Muñoz-Gómez, J ;
Cañete, JD .
MEDICINA CLINICA, 2004, 122 (09) :321-324
[25]   Quality of life response in rheumatoid arthritis patients treated with infliximab [J].
Novik, AA ;
Mesenova, T ;
Ionova, TI ;
Boitcov, SA ;
Kishtovich, A ;
Fedorenko, DA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :473-473
[26]   Lipid profile in patients with rheumatoid arthritis treated with TNF alpha antagonist infliximab [J].
Kotyla, PJ ;
Kucharz, EJ ;
Lewicki, M ;
Kotulska, AT .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 :406-407
[27]   CLINICAL CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS TO BE INTENSIFIED INFLIXIMAB THERAPY [J].
Oguma, A. ;
Irino, K. ;
Sawabe, T. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 :946-946
[28]   Influence of infliximab on circulating osteoprotegerin and its prognostic value in patients with rheumatoid arthritis [J].
Korzh, OM .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :249-250
[29]   Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment [J].
Harriman, G ;
Harper, LK ;
Schaible, TF .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 :61-64
[30]   Relation between serumlevels of infliximab, C-reactive protein and clinical response to infliximab in patients with rheumatoid arthritis. [J].
Wolbink, G ;
de Groot, E ;
Lems, W ;
Dijkmans, B ;
Nurmohamed, M ;
Tak, PP ;
Aarden, L ;
Voskuyl, A .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :S136-S136
12345